Oncorena Initiates the Phase I-II Clinical Trial with Orellanine in Advanced Kidney Cancer Patients at Karolinska University Hospital in Sweden

/PRNewswire/ -- Oncorena today announced the initiation of the Phase I-II clinical trial of the first-in-class compound orellanine in patients with advanced...

Related Keywords

Stockholm ,Sweden ,Gothenburg ,Vastra Gotalands Lan ,Swedish ,Lars Grundemar ,Jenny Nystr ,Prnewswire Oncorena ,Centre For Clinical Cancer ,Sweden Innovation Agency ,Karolinska University Hospital ,University Of Gothenburg ,Swedish Medical Products Agency ,Clinical Cancer Studies ,Chief Executive Officer ,Papillary Kidney ,Innovation Agency ,Oncorena Ab ,